quercetine
Doctor Micher Chrétien explains that this substance is already used to treat and prevent Ebola as well as the Zika virus. "In 2014, we had a crucial experiment with the national microbiology laboratory in Winnipeg. They were the only ones capable of handling the Ebola virus.
Treating a patient with quercetin will cost only $ 1.50 a day, according to Dr. Chrétien, "while the new antivirals that patients are currently using cost $ 1,000 a day."
recover from the coronavirus that causes COVID-19
A vegetable substance to overcome the coronavirus
Cure COVID-19
Against COVID-19 for people around the world.
- Concept: An idea being explored for its feasibility to build a product, service, or business model based on that idea
- A new application of an existing technology
Inexpensive and potentially very effective.
Quercetin 
In this context, the clinical trial process may begin shortly in China, since tablets had already been created and approved by the FDA, the American regulatory agency. "A small Swiss pharmaceutical company had done all the work of preparing high-dose quercetin" [...], relates the researcher. "We have someone who has millions of pills at their disposal and who is with us to give China the necessary medicines. We have them."
- Ancestral Technology & Practices
- Biotechnology / Bioengineering
Influenza A viruses (IAVs) cause seasonal pandemics and epidemics with 
high morbidity and mortality, which calls for effective anti-IAV agents.
 The glycoprotein hemagglutinin of influenza virus plays a crucial role 
in the initial stage of virus infection, making it a potential target 
for anti-influenza therapeutics development. Here we found that 
quercetin inhibited influenza infection with a wide spectrum of strains,
 including A/Puerto Rico/8/34 (H1N1), A/FM-1/47/1 (H1N1), and 
A/Aichi/2/68 (H3N2) with half maximal inhibitory concentration (IC50)
 of 7.756 ± 1.097, 6.225 ± 0.467, and 2.738 ± 1.931 μg/mL, respectively.
 Mechanism studies identified that quercetin showed interaction with the
 HA2 subunit. Moreover, quercetin could inhibit the entry of the H5N1 
virus using the pseudovirus-based drug screening system. This study 
indicates that quercetin showing inhibitory activity in the early stage 
of influenza infection provides a future therapeutic option to develop 
effective, safe and affordable natural products for the treatment and 
prophylaxis of IAV infections.
- Women & Girls
- Pregnant Women
- Children & Adolescents
- Elderly
- Rural
- Urban
- Poor
- Low-Income
- 3. Good Health and Well-Being
- Canada
- Canada
Thousands of people
none
Nobody care about about this simple solution
none